Cargando…

Cerebellar dysfunction and autism spectrum disorders – what do we know?

INTRODUCTION: Autism spectrum disorders (ASD) are complex neurodevelopmental conditions characterized by impairments in social cognition and repetitive behaviors with onset in early infancy. Deficits in emotion recognition, social perception, and communication have been identified as core symptoms o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinheiro Ramos, C., Alves, M., Marta, J., Ribeiro, R., Gamito, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595810/ http://dx.doi.org/10.1192/j.eurpsy.2023.551

Ejemplares similares

Estrogens in schizophrenia: What do we know?
por: Ferreira, L. Paulino, et al.
Publicado: (2021)

Cortico-Cerebellar Connectivity in Autism Spectrum Disorder: What Do We Know So Far?
por: Crippa, Alessandro, et al.
Publicado: (2016)

Pituitary Apoplexy in Pregnancy: What do We Know?
por: Gamito, Mariana Alves Patrício de Oliveira, et al.
Publicado: (2023)

Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

Autism Spectrum Disorder: Why Do We Know So Little?
por: Emberti Gialloreti, Leonardo, et al.
Publicado: (2018)

What we do not know about cerebellar systems neuroscience
por: Voogd, Jan
Publicado: (2014)

Dysfunctional breathing: what do we know?
por: Vidotto, Laís Silva, et al.
Publicado: (2019)

Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?
por: Descalço, N., et al.
Publicado: (2021)

Obsessive-Compulsive Disorder and suicide: what do we know up until now?
por: Salvadori, G., et al.
Publicado: (2022)

Suicide among physicians: what do we know about it?
por: Vaz, R. P., et al.
Publicado: (2023)

What do we know about lithium associated hypercalcemia?
por: Laherrán Cantera, N., et al.
Publicado: (2023)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Capgras Syndrome as a Manifestation of a Neurodegenerative Disease – What do we know?
por: Matias, M., et al.
Publicado: (2023)

THE PHYSICAL AND MENTAL HEALTH OF HOME HEALTHCARE WORKERS: WHAT DO WE KNOW AND WHAT CAN WE DO ABOUT IT?
por: Sterling, Madeline
Publicado: (2022)

Is fever good? What do we actually know?
por: Rhodes, Jonathan KJ
Publicado: (2015)

Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015)

Apples and oranges in HEMS – Do we know what we compare?
por: Rasmussen, Kristen, et al.
Publicado: (2015)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

The cognitive effects of esketamine: what do we know so far?
por: Barbosa, M., et al.
Publicado: (2022)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

The Co-Occurrence of Autism and Attention Deficit Hyperactivity Disorder in Children – What Do We Know?
por: Leitner, Yael
Publicado: (2014)

Attention-deficit/hyperactivity disorder and dementia – is there a link?
por: Pinheiro Ramos, C., et al.
Publicado: (2023)

Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
por: Cortese, Rosa, et al.
Publicado: (2022)

Inflammatory cytokines dysfunction in autism spectrum disorder
por: Ben Othman, A., et al.
Publicado: (2021)

Spectrum of MRI findings of foetal alcohol syndrome disorders—what we know and what we need to know!
por: Sharif, Saad, et al.
Publicado: (2023)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

The fragile X syndrome–autism comorbidity: what do we really know?
por: Abbeduto, Leonard, et al.
Publicado: (2014)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

What is Prevalence of Autism Spectrum Disorders in Republic of Georgia?
por: Zirakashvili, M., et al.
Publicado: (2022)

Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
por: Pinheiro, Rúben G. R., et al.
Publicado: (2021)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

AB089. What should we know role of finasteride in erectile dysfunction?
por: Shin, Yu Seob, et al.
Publicado: (2018)

Effects of the COVID-19 pandemic on mental health - what do we know so far?
por: Marguilho, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqm4qqvf282epnal25svv7k96p